Drug persistence and compliance affect patient-reported outcomes in overactive bladder syndrome (Q47873674)

6 February 2018

title

Drug persistence and compliance affect patient-reported outcomes in overactive bladder syndrome (English)

1 reference

6 February 2018

author name string

Tae Heon Kim

1

1 reference

6 February 2018

Myung-Soo Choo

2

1 reference

6 February 2018

Young-Joo Kim

3

1 reference

6 February 2018

Hyein Koh

4

1 reference

6 February 2018

Kyu-Sung Lee

5

1 reference

6 February 2018

publication date

24 December 2015

1 reference

6 February 2018

published in

Quality of Life Research

1 reference

6 February 2018

volume

25

1 reference

6 February 2018

issue

8

1 reference

6 February 2018

page(s)

2021-2029

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/s11136-015-1216-z

exact match

0 references

cites work

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

The prevalence of lower urinary tract symptoms in korean men aged 40 years or older: a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Effect of urgency symptoms on the risk of depression in community-dwelling elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Assessment of the Impact of Male Urinary Incontinence on Health-Related Quality of Life: A Population Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Medication compliance and persistence: terminology and definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Medication adherence: its importance in cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Psychometric Properties of the Korean Version of the Overactive Bladder Questionnaire (OAB-q) in a Korean Population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Medication adherence and persistence: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Long-term adherence to antimuscarinic therapy in everyday practice: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Overactive bladder medication adherence when medication is free to patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11136-015-1216-Z

An overview of the clinical use of antimuscarinics in the treatment of overactive bladder

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26701707

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparing adherence and persistence across 6 chronic medication classes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26701707

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Persistence with overactive bladder pharmacotherapy in a Medicaid population.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26701707

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11136-015-1216-Z

1 reference

6 February 2018

PubMed ID

26701707

1 reference

6 February 2018